Provaris Energy Ltd (ASX:PV1, OTC:GBBLF, FRA:WS90) has completed a $1 million placement to support key 2026 technical ...
The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip ...
LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...
St. Louis will host July workshops and a virtual meeting to present draft zoning development standards, share map updates, ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...
PARP inhibitors reshaped oncology when they first reached patients some 10 years ago, but they represent just one entry point into a much larger and more intricate biological network.
A new generation of reversible male contraceptives is advancing through clinical trials to expand family planning options.
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...
Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth- ...
(Nasdaq: EXEL) today announced results from the final analysis of the dual primary endpoint of overall survival (OS) in the subset of patients without active liver metastases (non-liver metastases, ...
The new agreement creates more competition but could leave officials "looking over their shoulders." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results